Literature DB >> 24858726

The differential roles of mTOR, ERK, and JNK pathways in invariant natural killer T-cell function and survival.

Jun Tian1, Li Liu, Xiangai Wang, Xuewu Sun, Suli Mu, Chuanjun Wu, Maoqiang Han.   

Abstract

Invariant natural killer T (iNKT) cell is a critical element for both innate and adaptive immunity. The quick responses of mature iNKT cells to TCR stimulation require activation of several different signaling pathways. However, the roles of these signaling pathways in mature iNKT cell biology remain incompletely understood. To address this issue, single signaling pathway was blocked with inhibitor in iNKT cells, and the roles of these signaling pathways were estimated. Results showed that mammalian target of rapamycin (mTOR) plays an essential role for cytokine production and survival in iNKT cells. In contrast, ERK and JNK are more important for iNKT cell effector function, but not survival. Our findings delineate the distinct roles of different signaling pathways in mature iNKT cells and therefore shed new light for modulating iNKT cell function in disease conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24858726     DOI: 10.1007/s10753-014-9933-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  31 in total

Review 1.  NKT cells: T lymphocytes with innate effector functions.

Authors:  Luc Van Kaer
Journal:  Curr Opin Immunol       Date:  2007-04-10       Impact factor: 7.486

Review 2.  Raising the NKT cell family.

Authors:  Dale I Godfrey; Sanda Stankovic; Alan G Baxter
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

3.  Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.

Authors:  Jason K Stuart; Steven P Bisch; Matilde Leon-Ponte; Jin Hayatsu; Delfina M Mazzuca; Saman Maleki Vareki; S M Mansour Haeryfar
Journal:  Int Immunopharmacol       Date:  2010-06-11       Impact factor: 4.932

4.  Negative regulation of mTOR activation by diacylglycerol kinases.

Authors:  Balachandra K Gorentla; Chi-Keung Wan; Xiao-Ping Zhong
Journal:  Blood       Date:  2011-02-10       Impact factor: 22.113

5.  The effect of the JNK inhibitor, JIP peptide, on human T lymphocyte proliferation and cytokine production.

Authors:  Michelle Melino; Charles S Hii; Shaun R McColl; Antonio Ferrante
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease.

Authors:  Wenya Wang; Leyu Shi; Yuanbin Xie; Chi Ma; Wenming Li; Xingwen Su; Shoujian Huang; Ruzhu Chen; Zhenyu Zhu; Zixu Mao; Yifan Han; Mingtao Li
Journal:  Neurosci Res       Date:  2004-02       Impact factor: 3.304

Review 7.  mTOR and lymphocyte metabolism.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Curr Opin Immunol       Date:  2013-05-28       Impact factor: 7.486

8.  Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation.

Authors:  Seth T Scanlon; Seddon Y Thomas; Caroline M Ferreira; Li Bai; Thomas Krausz; Paul B Savage; Albert Bendelac
Journal:  J Exp Med       Date:  2011-09-19       Impact factor: 14.307

9.  TSC1/2 signaling complex is essential for peripheral naïve CD8+ T cell survival and homeostasis in mice.

Authors:  Lianjun Zhang; Hongbing Zhang; Lanlan Li; Yi Xiao; Enyu Rao; Zhuang Miao; Hui Chen; Lina Sun; Hongran Li; Guangwei Liu; Yong Zhao
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 10.  Signaling for NKT cell development: the SAP-FynT connection.

Authors:  Christine Borowski; Albert Bendelac
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

View more
  3 in total

1.  TRAF3IP3 at the trans-Golgi network regulates NKT2 maturation via the MEK/ERK signaling pathway.

Authors:  Xinwei Zhang; Ke Wang; Weijia Zhao; Li Cao; Shusong Zhang; Rong Jin; Xiuyuan Sun; Jie Hao; Xiaojun Huang; Mingzhao Zhu; Hounan Wu; Hongshan Zhao; Qing Ge
Journal:  Cell Mol Immunol       Date:  2019-05-10       Impact factor: 11.530

2.  CXXC finger protein 4 inhibits the CDK18-ERK1/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1/MIR100HG pathway.

Authors:  Ping Li; Dongfang Ge; Pengfei Li; Fangyong Hu; Junfeng Chu; Xiaojun Chen; Wenbo Song; Ali Wang; Guangyu Tian; Xiang Gu
Journal:  J Cell Mol Med       Date:  2020-07-26       Impact factor: 5.310

Review 3.  Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation.

Authors:  Thomas Yul Avery; Natalie Köhler; Robert Zeiser; Tilman Brummer; Dietrich Alexander Ruess
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.